Evidence map›Paper›PMID 30426186›Full record

ArticleWorld journal of surgery2019

Indications and Outcomes of a Cross-Linked Porcine Dermal Collagen Mesh (Permacol) for Complex Abdominal Wall Reconstruction: A Multicenter Audit.

Alexandre Doussot, Fawaz Abo-Alhassan, Sofiane Derbal, Isabelle Fournel, Faustin Kasereka-Kisenge, Tatiana Codjia, Haitham Khalil, Vincent Dubuisson, Haythem Najah, Alexis Laurent and 5 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in World journal of surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Outcomes of Biosynthetic and Synthetic Mesh in Ventral Hernia Repair.Plastic and reconstructive surgery. Global open · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alexandre DoussotDepartment of Digestive Surgery, University Hospital of Dijon, 14 Rue Paul Gaffarel, 21079, Dijon, France.
Fawaz Abo-AlhassanDepartment of Digestive Surgery, University Hospital of Dijon, 14 Rue Paul Gaffarel, 21079, Dijon, France.
Sofiane DerbalDepartment of Digestive Surgery, University Hospital of Limoges, Limoges, France.
Isabelle FournelINSERM, CIC1432, Clinical Epidemiology Unit, 21000, Dijon, France.
Faustin Kasereka-KisengeDepartment of Digestive Surgery, Pitié-Salpétrière Hospital, Paris, France.
Tatiana CodjiaDepartment of Digestive Surgery, University Hospital of Rouen, Rouen, France.
Haitham KhalilDepartment of Digestive Surgery, University Hospital of Rouen, Rouen, France.
Vincent DubuissonDepartment of Digestive Surgery, University Hospital of Bordeaux, Bordeaux, France.
Haythem NajahDepartment of Digestive Surgery, Pitié-Salpétrière Hospital, Paris, France.
Alexis LaurentDepartment of Digestive Surgery, Henri Mondor Hospital, Créteil, France.
Benoît RomainDepartment of Digestive Surgery, University Hospital of Strasbourg, Strasbourg, France.
Christophe BarratDepartment of Digestive Surgery, Jean Verdier Hospital, Bondy, France.
Christophe TrésalletDepartment of Digestive Surgery, Pitié-Salpétrière Hospital, Paris, France.
Muriel MathonnetDepartment of Digestive Surgery, University Hospital of Limoges, Limoges, France.
Pablo Ortega-DeballonDepartment of Digestive Surgery, University Hospital of Dijon, 14 Rue Paul Gaffarel, 21079, Dijon, France. pablo.ortega-deballon@chu-dijon.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTo reduce the occurrence of complications in the setting of high-risk patients with contaminated operative field, a wide range of biologic meshes has been developed. Yet, few series have reported outcomes after abdominal wall repair (AWR) using such meshes. Permacol is an acellular porcine dermal collagen matrix with a cross-linked pattern. This study reports short- and long-term outcomes after AWR for incisional hernia using Permacol. MATERIALS AND

methodsAll consecutive patients undergoing single-stage open AWR using Permacol mesh at eight university hospitals were included. Mortality, complication and hernia recurrence rates were assessed. Independent risk factors for complications and hernia recurrence were identified with logistic regression and Fine and Gray analysis, respectively.

resultsOverall, 250 patients underwent single-stage AWR with Permacol. Nearly 80% had a VHWG grade 3 or 4 defect. In-hospital mortality and complication rates were 4.8% (n = 12) and 61.6% (n = 154), respectively. Reintervention for complications was required for 74 patients (29.6%). Mesh explantation rate was 4% (n = 10). Independent risk factors for complications were smoking, defect size and VHWG grade. After a mean follow-up time of 16.8 months (± 18.1 months), 63 (25.2%) experienced hernia recurrence. One-, 2- and 3-year RFS were 90%, 74% and 57%, respectively. Previous AWR, mesh location and the need for reintervention were independent predictors of hernia recurrence. DISCUSSION: Single-stage AWR is feasible using Permacol. Mortality and complication rates are high due to patients' comorbidities and the degree of contamination of the operative field. Given the observed recurrence rate, the benefit of biologics remains to be ascertained.

Indexed as

Abdominal WallAbdominoplastyAgedAnimalsBiocompatible MaterialsCollagenFemaleHerniorrhaphyHospital MortalityHumansIncisional HerniaMaleMiddle AgedPostoperative ComplicationsRecurrenceReoperationBiocompatible MaterialsCollagenPermacol

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.